 |
Society formed to provide support to those affected by MSThe National Multiple Sclerosis Society (NMSS) has been launched in Abu Dhabi, to deliver support programmes, improve healthcare services and provide a community for people affected by MS across the UAE. More… |
 |
ADSCC to begin game-changing multiple sclerosis treatmentAbu Dhabi Stem Cells Centre (ADSCC), a leading research institute in the region, will begin a ground-breaking clinical trial to help treat multiple sclerosis. The stem cell research hub will begin the recruitme More… |
 |
Bahrain to start work on new MS facility in 2020Bahraini authorities said work is set to start on a specialised multiple sclerosis (MS) centre within the Muharraq Medical Complex early next year. A 100-bed facility, a first-of-its-kind in the Gulf region, will be ready by the f More… |
|
Bahrain to start work on new MS facility in 2020Bahraini authorities said work is set to start on a specialised multiple sclerosis (MS) centre within the Muharraq Medical Complex early next year. A 100-bed facility, a first-of-its-kind in the Gulf region, will be ready by the f More… |
 |
Work set to start on Bahrain medical complexBahraini authorities said work would soon begin on a BD1.7-million ($4.5 million) multiple sclerosis centre in the Muharraq region of the kingdom. The 100-bed facility, being developed as part of the Muharraq Medical Complex, is set for completi More… |
|
Work set to start on Bahrain medical complexBahraini authorities said work would soon begin on a BD1.7-million ($4.5 million) multiple sclerosis centre in the Muharraq region of the kingdom. The 100-bed facility, being developed as part of the Muharraq Medical Complex, is set for completi More… |
 |
Merck's drug for multiple sclerosis wins UAE approvalUS pharma group Merck said the UAE Ministry of Health and Prevention has approved the registration of its Mavenclad (cladribine tablets) for the treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clini More… |
|
Merck's drug for multiple sclerosis wins UAE approvalUS pharma group Merck said the UAE Ministry of Health and Prevention has approved the registration of its Mavenclad (cladribine tablets) for the treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clini More… |
 |
Global experts to discuss MS research in DubaiNeurologists from across the world will discuss the latest research and trends in multiple sclerosis (MS) at an upcoming congress in Dubai. The first MENACTRIMS Congress will be organised by the Middle East North Africa Committee More… |
 |
University of Ain Shams opens MS treatment unitThe University of Ain Shams, in cooperation with Novartis Pharmaceuticals, has opened Egypt’s first medical unit for the treatment of multiple sclerosis (MS). An autoimmune disease that affects the central nervous system, MS More… |
